Annual Shareholders Equity
$243.03 M
+$7.84 M+3.33%
December 1, 2024
Summary
- As of March 14, 2025, FULC annual stockholders equity is $243.03 million, with the most recent change of +$7.84 million (+3.33%) on December 1, 2024.
- During the last 3 years, FULC annual shareholders equity has risen by +$31.50 million (+14.89%).
- FULC annual shareholders equity is now at all-time high.
Performance
FULC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$243.03 M
-$14.26 M-5.54%
December 31, 2024
Summary
- As of March 14, 2025, FULC quarterly stockholders equity is $243.03 million, with the most recent change of -$14.26 million (-5.54%) on December 31, 2024.
- Over the past year, FULC quarterly shareholders equity has increased by +$7.84 million (+3.33%).
- FULC quarterly shareholders equity is now -17.96% below its all-time high of $296.26 million, reached on March 31, 2023.
Performance
FULC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
FULC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.3% | +3.3% |
| 3 y3 years | +14.9% | +3.3% |
| 5 y5 years | +178.9% | +3.3% |
FULC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.2% | -18.0% | +51.2% |
| 5 y | 5-year | at high | +178.9% | -18.0% | +244.1% |
| alltime | all time | at high | >+9999.0% | -18.0% | +354.6% |
Fulcrum Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $243.03 M(-5.5%) |
| Dec 2024 | $243.03 M(+3.3%) | - |
| Sep 2024 | - | $257.29 M(-6.0%) |
| Jun 2024 | - | $273.79 M(+28.2%) |
| Mar 2024 | - | $213.59 M(-9.2%) |
| Dec 2023 | $235.19 M(+18.2%) | $235.19 M(-7.9%) |
| Sep 2023 | - | $255.46 M(-7.2%) |
| Jun 2023 | - | $275.43 M(-7.0%) |
| Mar 2023 | - | $296.26 M(+48.9%) |
| Dec 2022 | $198.94 M(-6.0%) | $198.94 M(-10.1%) |
| Sep 2022 | - | $221.41 M(+37.7%) |
| Jun 2022 | - | $160.75 M(-15.0%) |
| Mar 2022 | - | $189.16 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $211.54 M(+122.2%) | $211.54 M(-8.3%) |
| Sep 2021 | - | $230.61 M(+108.0%) |
| Jun 2021 | - | $110.89 M(-13.2%) |
| Mar 2021 | - | $127.75 M(+34.2%) |
| Dec 2020 | $95.18 M(+9.2%) | $95.18 M(-9.3%) |
| Sep 2020 | - | $104.98 M(-14.0%) |
| Jun 2020 | - | $122.13 M(+72.9%) |
| Mar 2020 | - | $70.63 M(-19.0%) |
| Dec 2019 | $87.15 M(+14.7%) | $87.15 M(-14.7%) |
| Sep 2019 | - | $102.13 M(+91.1%) |
| Jun 2019 | - | $53.45 M(-18.3%) |
| Mar 2019 | - | $65.45 M(-13.9%) |
| Dec 2018 | $76.00 M(+5648.9%) | $76.00 M |
| Dec 2017 | $1.32 M | - |
FAQ
- What is Fulcrum Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual shareholders equity year-on-year change?
- What is Fulcrum Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly shareholders equity year-on-year change?
What is Fulcrum Therapeutics annual stockholders equity?
The current annual shareholders equity of FULC is $243.03 M
What is the all time high annual shareholders equity for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual stockholders equity is $243.03 M
What is Fulcrum Therapeutics annual shareholders equity year-on-year change?
Over the past year, FULC annual stockholders equity has changed by +$7.84 M (+3.33%)
What is Fulcrum Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of FULC is $243.03 M
What is the all time high quarterly shareholders equity for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly stockholders equity is $296.26 M
What is Fulcrum Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, FULC quarterly stockholders equity has changed by +$7.84 M (+3.33%)